Market Currents

• Tuesday, December 16, 2008

• 10:00 AM Chemical firm Cabot (CBT) is down 13.5% in early trading on a downgrade. KeyBanc says it's unlikely investors will see an earnings benefit from the restructuring announced last week for quite some time. Comment!

• Friday, August 29, 2008

• 08:36 AM JPMorgan likes specialty chemicals firm Cabot (CBT). "Raw material costs... reached a relative peak, and Cabot's price increases are contractually delayed by a quarter," it says, upgrading to Overweight. Short squeeze alert. Comment!